Mi Liu

Dr. Mi Liu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in Hepatology Communications
Verified
Journal Article
Open access
RZRuhan Zhang
Ruhan Zhang
ZYZhaobo Yan
Zhaobo Yan
HZHuan Zhong
Huan Zhong
RLRong Luo
Rong Luo
WLWeiai Liu
Weiai Liu
MLMi Liu
Mi Liu
With an increasing prevalence, metabolic dysfunction–associated steatotic liver disease (MASLD) has become a major global health problem. MASLD is well-known as a multifactorial disease. Mitochondrial dysfunction and alterations in the gut bacteria are 2 vital events in MASLD. Recent studies have highlighted the cross-talk between microbiota and mitochondria, and mitochondria are recognized as pivotal targets of the gut microbiota to modulate the host's physiological state. Mitochondrial dysfunction plays a vital role in MASLD and is associated with multiple pathological changes, including hepatocyte steatosis, oxidative stress, inflammation, and fibrosis. Metabolites are crucial mediators of the gut microbiota that influence extraintestinal organs. Additionally, regulation of the composition of gut bacteria may serve as a promising therapeutic strategy for MASLD. This study reviewed the potential roles of several common metabolites in MASLD, emphasizing their impact on mitochondrial function. Finally, we discuss the current treatments for MASLD, including probiotics, prebiotics, antibiotics, and fecal microbiota transplantation. These methods concentrate on restoring the gut microbiota to promote host health.

7 April 2025 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
JZJingying Zhou
Jingying Zhou
PLPenghui Lu
Penghui Lu
HHHaolong He
Haolong He
RZRuhan Zhang
Ruhan Zhang
DYDican Yang
Dican Yang
GZGuoshan ZHANG
Guoshan ZHANG
Inflammatory bowel disease (IBD) includes chronic inflammatory conditions, such as Crohn's disease and ulcerative colitis, characterized by impaired function of the intestinal mucosal epithelial barrier. In recent years, ferroptosis, a novel form of cell death, has been confirmed to be involved in the pathological process of IBD and is related to various pathological changes, such as oxidative stress and inflammation. Recent studies have further revealed the complex interactions between the microbiome and ferroptosis, indicating that ferroptosis is an important target for the regulation of IBD by the gut microbiota and its metabolites. This article reviews the significant roles of gut microbial metabolites, such as short-chain fatty acids, tryptophan, and bile acids, in ferroptosis in IBD. These metabolites participate in the regulation of ferroptosis by influencing the intestinal microenvironment, modulating immune responses, and altering oxidative stress levels, thereby exerting an impact on the pathological development of IBD. Treatments based on the gut microbiota for IBD are gradually becoming a research hotspot. Finally, we discuss the potential of current therapeutic approaches, including antibiotics, probiotics, prebiotics, and fecal microbiota transplantation, in modulating the gut microbiota, affecting ferroptosis, and improving IBD symptoms. With a deeper understanding of the interaction mechanisms between the gut microbiota and ferroptosis, it is expected that more precise and effective treatment strategies for IBD will be developed in the future.

Verified
Journal Article
Open access
PDF file
HXHaihua Xie
Haihua Xie
JJJia Jiang
Jia Jiang
SCSihui Cao
Sihui Cao
XXXuan Xu
Xuan Xu
JZJingying ZHOU
Jingying ZHOU
MLMi Liu
Mi Liu
Mild cognitive impairment (MCI) represents a transitional stage between normal aging and dementia, often considered critical for dementia prevention. Despite its significance, no effective clinical treatment for MCI has yet been established. Emerging evidence has demonstrated a strong association between trimethylamine-N-oxide (TMAO), a prominent metabolite derived from the gut microbiota, and MCI, highlighting its potential as a biomarker and therapeutic target. TMAO has been implicated in increasing MCI risk through its influence on factors such as hypertension, cardiovascular disease, depression, diabetes, and stroke. Moreover, it contributes to MCI by promoting oxidative stress, disrupting the blood–brain barrier, impairing synaptic plasticity, inducing inflammation, causing mitochondrial metabolic disturbances, and facilitating abnormal protein aggregation. This review further explores therapeutic strategies targeting TMAO to mitigate MCI progression.

6 February 2024 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
HHHaolong He
Haolong He
JZJingying Zhou
Jingying Zhou
XXXuan Xu
Xuan Xu
PZPinxi Zhou
Pinxi Zhou
HZHuan Zhong
Huan Zhong
MLMi Liu
Mi Liu
The intestine is the largest mechanosensitive organ in the human body whose epithelial cells, smooth muscle cells, neurons and enteroendocrine cells must sense and respond to various mechanical stimuli such as motility, distension, stretch and shear to regulate physiological processes including digestion, absorption, secretion, motility and immunity. Piezo channels are a newly discovered class of mechanosensitive ion channels consisting of two subtypes, Piezo1 and Piezo2. Piezo channels are widely expressed in the intestine and are involved in physiological and pathological processes. The present review summarizes the current research progress on the expression, function and regulation of Piezo channels in the intestine, with the aim of providing a reference for the future development of therapeutic strategies targeting Piezo channels.

7 May 2025 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
PZPinxi Zhou
Pinxi Zhou
RZRuhan Zhang
Ruhan Zhang
LXLiangmei Xian
Liangmei Xian
LNLe Ning
Le Ning
PLPenghui Lu
Penghui Lu
MLMi Liu
Mi Liu
Sciatic nerve injury is one of the most frequent peripheral nerve injuries in the world. The loss of motor and sensory function, along with chronic pain caused by sciatic nerve injury, significantly impacts patients’ quality of life. However, there are numerous restrictions on in vitro studies on the regeneration and healing of sciatic nerve damage. In contrast, in vivo studies can more accurately mimic clinical pathology through a variety of experimental animal models and a variety of modeling methods. However, the selection of different models has its focus, so this paper reviews the selection of experimental animals, modeling methods, and common treatment protocols. The advantages and disadvantages of each species are discussed, and the modeling methods of five common sciatic nerve injury models, along with their characteristics and applications, are highlighted. Additionally, we briefly summarize the common treatments for sciatica and nerve injury. This review is of great significance for further exploring model selection, the mechanisms underlying sciatic nerve injury, and therapies for nerve regeneration and repair.

3 March 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JJJia Jiang
Jia Jiang
HXHaihua Xie
Haihua Xie
SCSihui Cao
Sihui Cao
XXXuan Xu
Xuan Xu
JZJingying Zhou
Jingying Zhou
MLMi Liu
Mi Liu
Post-stroke depression (PSD) is one of the most common and devastating neuropsychiatric complications in stroke patients, affecting more than one-third of survivors of ischemic stroke (IS). Despite its high incidence, PSD is often overlooked or undertreated in clinical practice, and effective preventive measures and therapeutic interventions remain limited. Although the exact mechanisms of PSD are not fully understood, emerging evidence suggests that the gut microbiota plays a key role in regulating gut-brain communication. This has sparked great interest in the relationship between the microbiota-gut-brain axis (MGBA) and PSD, especially in the context of cerebral ischemia. In addition to the gut microbiota, another important factor is the gut barrier, which acts as a frontline sensor distinguishing between beneficial and harmful microbes, regulating inflammatory responses and immunomodulation. Based on this, this paper proposes a new approach, the microbiota-immune-barrier axis, which is not only closely related to the pathophysiology of IS but may also play a critical role in the occurrence and progression of PSD. This review aims to systematically analyze how the gut microbiota affects the integrity and function of the barrier after IS through inflammatory responses and immunomodulation, leading to the production or exacerbation of depressive symptoms in the context of cerebral ischemia. In addition, we will explore existing technologies that can assess the MGBA and potential therapeutic strategies for PSD, with the hope of providing new insights for future research and clinical interventions.